Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.09 – $0.15
100% from low
Exchange
OTC Link
OS
ALLERGY THERAPEUTICS PLC
No one on the platform currently holds AGYTF.
No tracked institution reports a position in AGYTF as of their last filing.
No one on the platform has traded AGYTF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $348M | +337.9% | $0.01 | $0.01–$0.01 | 12.1× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 2 of the last 5 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-03-31 | $-0.01 | $-0.01 | +0.0% |
| 2024-11-06 | $-0.01 | $-0.01 | +0.8% |
| 2023-06-30 | $-0.01 | $-0.03 | -153.8% |
| 2022-12-31 | $-0.01 | $-0.01 | -30.5% |
| 2022-06-30 | $-0.01 | $-0.02 | -72.0% |
| $313M |
| — |
| JCRRFJCR Pharmaceuticals Co., Ltd. | $3.32 | +0.00% | $405M | — |
| LBLTFLattice Biologics Ltd. | $0.00 | +0.00% | $16545 | — |
Source: Financial Modeling Prep · peers by sector/industry